|
⚲
|
| Keyboard |
| Oracle Corp
✚
|
|
|---|---|
| CIK # | 0001012622, 0001341439 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| CM Life Sciences Inc | 0.1 | ||
| Ardelyx Inc | 0.0 | ||
| Biohaven Ltd | 0.0 | ||
| Quidelortho Corp | 0.0 | ||
| Personalis Inc | 0.0 | ||
| Teladoc Inc | 0.0 | ||
| Taysha Gene Therapies Inc | 0.0 | ||
| CAVA Group Inc | 0.0 | ||
| Edgewise Therapeutics Inc | 0.0 | ||
| Biogen IDEC Inc | 0.0 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001012622] | |
| 3 | [0001012622] | |
| 4 | [0001012622] | |
| 10-K | [0001341439] | |
| 10-Q | [0001341439] | |
| 3 | [0001341439] | |
| 4 | [0001341439] | |
| 8-K | [0001341439] | |
| SC 13D | [0001341439] | |
| SC 13G | [0001341439] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Oracle Corp | |
| Henley Jeffrey | |
| Boskin Michael J | |
| Mihaljevic Tomislav | |
| Fairhead Rona Alison | |
| Chizen Bruce R | |
| Berg Jeffrey | |
| Ablo Awo | |
| Rusckowski Stephen H | |
| Moorman Charles W | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Oracle Corp ORCL
Common Stock
|
2026-02-09 | Sell | 10,000 | $155.23 | 1,552,300 |
|
Oracle Corp ORCL
Restricted Stock Unit · derivative
|
2026-01-23 | Grant | 337.78 | $177.16 | 59,841 |
|
Oracle Corp ORCL
Common Stock
|
2026-01-15 | Sell | 35,000 | $194.89 | 6,821,150 |
|
Oracle Corp ORCL
Common Stock
|
2025-12-24 | Sell | 15,000 | $196.89 | 2,953,350 |
|
Oracle Corp ORCL
Common Stock
|
2025-12-23 | Other | 199,071 | $0.00 | |
|
Oracle Corp ORCL
Common Stock
|
2025-12-23 | Sell | 2,223 | $196.61 | 437,064 |
|
Oracle Corp ORCL
Common Stock
|
2025-12-22 | Gift | 5,000 | $0.00 | |
|
Oracle Corp ORCL
Common Stock
|
2025-12-19 | Sell | 10,000 | $192.52 | 1,925,200 |
|
Oracle Corp ORCL
Common Stock
|
2025-12-05 | Tax withheld | 5,740 | $214.33 | 1,230,254 |
|
Oracle Corp ORCL
Common Stock
|
2025-12-05 | Option exercise | 11,016 | $0.00 | |
|
Oracle Corp ORCL
Restricted Stock Unit · derivative
|
2025-12-05 | Option exercise | 11,016 | $0.00 | |
|
Oracle Corp ORCL
Restricted Stock Unit · derivative
|
2025-11-18 | Grant | 793 | $0.00 | |
|
Oracle Corp ORCL
Common Stock
|
2025-10-28 | Sell | 4,226 | $284.31 | 1,201,494 |
|
Oracle Corp ORCL
Common Stock
|
2025-10-28 | Sell | 13,373 | $282.56 | 3,778,675 |
|
Oracle Corp ORCL
Common Stock
|
2025-10-28 | Sell | 9,042 | $281.58 | 2,546,046 |
|
Oracle Corp ORCL
Common Stock
|
2025-10-28 | Sell | 22,724 | $283.63 | 6,445,208 |
|
Oracle Corp ORCL
Restricted Stock Unit · derivative
|
2025-10-23 | Grant | 142.94 | $280.07 | 40,033 |
|
Oracle Corp ORCL
Stock Option · derivative
|
2025-10-23 | Grant | 428,465 | $0.00 | |
|
Oracle Corp ORCL
Restricted Stock Unit · derivative
|
2025-10-23 | Grant | 35,706 | $0.00 | |
|
Oracle Corp ORCL
Restricted Stock Unit · derivative
|
2025-10-23 | Grant | 32,135 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||